Leucovorin News
Pooled Analysis of Safety and Efficacy of Oxaliplatin Plus Fluorouracil/Leucovorin Administered Bimonthly in Elderly Patients With Colorectal Cancer
PURPOSE: Oxaliplatin, fluorouracil, and leucovorin are commonly used to treat advanced and resected colorectal cancer. This analysis compares the safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered...
Royalty income set to soar for Strathclyde cancer treatment
Cancer patients in America are set to benefit from a drug pioneered at the University of Strathclyde following a licensing deal with a US pharmaceutical company.
University's cancer drug windfall
A SCOTTISH university is in line for a multi-million-pound windfall after a cancer drug it pioneered was licensed for sale in the United states.
International deal for university of strathclyde cancer drug
Cancer patients in America are set to benefit from a drug pioneered at the University of Strathclyde following a licensing deal with a US pharmaceutical company.
Colorectal Cancer Response to FOLFIRI-3 Treatment Evaluated
Treating colorectal cancer with FOLFIRI-3 (double infusion of irinotecan combined with leucovorin 5-fluorouracil [LV5FU]) after FOLFOX proves to be promising.